Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

NARecruitingINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

February 28, 2039

Study Completion Date

February 28, 2039

Conditions
Prostatic NeoplasmAdenocarcinomaNeoplasm RecurrenceNeoplasm Metastasis
Interventions
OTHER

Standard care

"Extra blood collection for dosages Urine collection for the dosage of non-persistent pollutants, isolation of extracellular vesicles released in urine, analysis of the microbiome, metagenomics to obtain a complete description of the bacterial functions represented as well as other microorganisms present, metabolome profiling and identification and/or assays of any other biological compound of interest strictly related to the specific objectives of the research.~Saliva collection for the extraction of the constitutional DNA. An interview using a structured questionnaire A quality of live auto-questionnaire"

Trial Locations (2)

35000

NOT_YET_RECRUITING

CHU of Rennes, Rennes

97159

RECRUITING

CHU of Guadeloupe, Pointe-à-Pitre

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Centre Hospitalier Universitaire de la Guadeloupe

OTHER